Insiders · Profile

EMBL Technology Fund II GmbH & Co. KG

10% owner at X4 Pharmaceuticals. Filing since 20 Nov 2017. CIK 0001722607

Company
Date
Role
Action
Shares
Amount
Of holding
20 Nov 2017
10% owner
Bought
20,000
$200.00K
5.7%
1 decision on file.